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Staging of endometrial cancer
by hysteroscopy
H. S. CRONJE, C. J. C. DEALE
Summary
Twenty-four consecutive patients with endometrial
adenocarcinoma were staged pre-operatively by
hysteroscopy and by fractional dilatation and curet-
tage (0 & C) to evaluate the accuracy of each
method in differentiating between International
Federation of Gynaecology and Obstetrics stage I
and 11 cancer. Hysteroscopic staging was correct in
16 patients (69.6%) and incorrect in 7 (30,4%). In 1
additional patient hysteroscopy failed to diagnose
the endometrial cancer. 0 & C staged 16 patients
correctly (66.7%) and 8 incorrectly (33.3%). Where
the hysteroscopic and 0 & C stagings correlated. the
staging was correct in 16 patients (75%) and incorrect
in 4 (25%). Therefore hysteroscopy and 0 &C are of
similar value in the pre-operative staging of endo-
metrial adenocarcinoma and their combined use has
a slight advantage..
S AIr Med J 1988; 73: 716-717.
Hysteroscopy is a relatively new development in gynaecology
and its usefulness in the diagnosis and localisation of endo-
metrial cancer has been inadequately evaluated. Diagnostic
fractional dilatation and curenage (D & C) is routinely per-
formed in the work-up of endometrial cancer, but it is a blind
procedure with inherent inadequacies. A lesion may pass
undiagnosed by D & C or its localisation may be misinter-
preted. Hysteroscopy may improve the gynaecologist's ability
to diagnose and localise the lesion accurately.
A study was undertaken to evaluate the accuracy of hystero-
scopy iJ). localising endometrial cancer in order to differentiate
between International Federation of Gynaecology and Obste-
trics (FIGO) stage I and II disease.
Patients and methods
Thirty-seven consecutive patients with proven or suspected endo-
metrial adenocarcinoma were prospectively examined with a
hysteroscope over a period of 24 months. Of these, 7 patients did
not have endometrial cancer, 5 had mixed Mullerian mesodermal
rumours and 1 hysteroscopy failed because of uterine perforation
in a patient with stage IV adenocarcinoma of the endometrium.
The remaining 24 patients with histologically proven adenocarci-
noma were included in this analysis.
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All hysteroscopic procedures and fractional D & Cs were done
by one of the authors (H.S.C.) and the histology was reviewed by
the other (C.J.C.D.). The hysteroscopy was done immediately
before D & C. If a patient had had a previous D & C, the D & C
was repeated and the second staging by fractional D & C was used
in this srudy. Hysteroscopy was performed with a Storz hystero-
scope No. 26165A with saline or Dextran 40% distension of the
uterus. The aim was to localise the inferior margin of the tumour
and to determine whether the tumour extended to the endocervix
or nOL
Mter hysteroscopy and D & C, all patients underwent total
abdominal hysterectomy and bilateral salpingo-oophorectomy. The
uterine specimens were carefully ex~ed for endocervical in-
volvement of endometrial adenocarcinoma. When infiltration of
endometrial cancer was present within the endocervix the patient
was classified as having stage II disease and those without infil-
tration were classed as stage I. The fmal histological staging was
then compared with the previous hysteroscopic staging and the
staging at D & C.
Results
The hysteroscopic staging was correct in -16 of 23 patients (69,6%)
and incorrect in 7 (30,4%). In 1 additional patient the endometrial
adenocarcinoma was not diagnosed at hysteroscopy. The staging at
D & C was also correct in 16 of 24 patients (66,7%) and incorrect
in 8 (33,3%) (Table I). In 5 patients the hysteroscopy was done
elsewhere without a D & C frrst or without previous knowledge of
the diagnosis. In these 5 patients the hysteroscopic staging was
correct in only 2 and D & C staging correct in 4. When the
hysteroscopic and D & C staging were similar, both were correct
in 12 of 16 patients (75%) and incorrect in 4 (25%).
TABLE I. PRE-OPERATIVE STAGING AT HYSTEROSCOPY
AND FRACTIONAL D & C v. FINAL POSTOPERATIVE
HISTOLOGICAL STAGING
Final staging
FIGO I FIGO 11
Hysteroscopy
Correct 14* 2
Incorrect 3 4t
D&C
Correct 13* 3
Incorrect 4 4
,.. Including 2 patients with stage IV disease but without endocervica,l involvement
of tumour.
In 1 additional patient hysteroscopy failed to diagnose the carcinoma.
Discussion
Cervical involvement may vary between free tumour cells in
the endocervical canal and endometrial infIltration of the
endocervix. 1 In this study only endometrial infiltration was
used as a criterion for endocervical involvement of endometrial
cancer. Free rumour cells can be found within the endocervical
mucus but are unlikely to cause spread of disease.
Several pitfalls should be avoided in the pre-operative staging
of endometrial cancer. It was difficult to locate the endocervical
os in many patients both at hysteroscopy and D & C. In
postmenopausal women the uterus may be small (± 6 cm in
total length) but with a relatively long endocervical canal (± 4
cm). On the other hand, a uterus of 10 cm length may have an
endocervical canal of only 3 cm. In some patients the endo-
cervical ring was incompetent and extremely difficult to locate
both by hysteroscopy and D & C. In rare cases it was virtually
impossible to decide where the junction between endocervix
and endometrium was.
A second problem at hysteroscopy was the localisation of
the inferior margin of the tumour. Well-differentiated exophytic
lesions were easily located (Fig. I). Poorly differentiated lesions,
which tended to infiltrate diffusely into neighbouring tissues,
were difficult to locate. In these cases, D & C may be superior
in staging.
Fig. 1. An exophytic endometrial adenocarcinoma (T) (centre)
seen through the hysteroscope just above the endocervix (E)
(peripherally on left).
Bleeding is another problem encountered at hysteroscopy.
This may be a major problem during diagnosis when the
whole uterine cavity has to be visualised. For staging only the
inferior margin of the tumour need be seen. This was not
difficult even in patients with active bleeding.
Is hysteroscopy safe in patients with endometrial carcinoma?
Between 1976 and 1979 hysterography was used in certain
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centres and considered safe although not of much value. 2-4
Tumour cells do spread spontaneously through the fallopian
tubes5 and procedures such as hysteroscopy, hysterography
and even D & C may exaggerate this process. No evidence
could be found that these procedures increase the risk for
metastases, even though D & C may cause dissemination of
tumour cells into the blood stream.6- 8 In this study, the disten-
sion pressure at hysteroscopy was always kept at 70 mmHg or
below which is well below the official maximum of 120
mmHg.8
In conclusion, hysteroscopy and D & C are of similar value
in the staging of endometrial cancer, with a sensitivity of about
67%. With combined use the sensitivity rises slightly to 75%
when the staging of both methods correlated. These figures
are lower than expected and confirm that the correct pre-
operative staging of endometrial cancer is an extremely difficult
procedure. The Hamou microhysteroscope is claimed to be
more sensitive than the conventional hysteroscope and fractional
D & C,9 but experience with this relatively new instrument is
limited.
In view of the inadequacy of these procedures, prehysterec-
tomy treatment with radium should be omitted and a fresh
operative specimen carefully scrutinised for the fmal histological
typing of the lesion, depth of myometrial invasion, cervical
involvement by the lesion, and metastases to tubes, ovaries
and other sites. lO
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